drugset / Trial / NCT04361136

Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream

NCT04361136

Phase 1 Completed 35 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindOther

Summary

This is a single-centre, randomised, vehicle-controlled, double-blind, within-subject comparison phase 1 clinical trial. The trial is designed to find out if delgocitinib cream can cause skin irritation after light exposure in people with healthy skin.

Timeline

Start
2020-04-23
Primary completion
2020-05-30
Completion
2020-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Delgocitinib Small molecule 1 unknown Topical
Subject Delgocitinib Small molecule 3 unknown Topical
Subject Delgocitinib Small molecule 8 unknown Topical
Subject Delgocitinib Small molecule 20 unknown Topical

Indications

No indication recorded.